State Street Corporation 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 12:37 pm Sale |
2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
STATE STREET CORP STT |
2,625,685 4.700% |
-553,383 (-17.41%) |
Filing |
| 2023-02-08 09:25 am Purchase |
2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
STATE STREET CORP STT |
3,179,068 5.790% |
186,186 (+6.22%) |
Filing |
| 2022-02-09 4:36 pm Purchase |
2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
STATE STREET CORP STT |
2,992,882 5.510% |
2,992,882 (New Position) |
Filing |